Steering Committee
Rashmi Barbhaiya, PhD, CEO and Managing Director, Advinus Therapeutics
Seth F. Berkley, MD President and CEO, International AIDS Vaccine Initiative
Joshua Boger, PhD, President and CEO, Vertex Pharmaceuticals
Brook Byers, Partner, Kleiner, Perkins, Caulfield, & Byers
Gail H. Cassell, PhD, Vice President, Scientific Affairs, Eli Lilly & Co.
Yves Champey, MD, Founding Chairman, Drugs for Neglected Diseases Initiative
Maria C. Freire, PhD, President and CEO, Global Alliance for TB Drug Development
David P. Holveck, President, Johnson & Johnson Development Corporation
Peter J. Hotez, MD, PhD, Professor and Chair, Dept of Microbiology, Immunology and Tropical Medicine George Washington University Medical Center
Mark Kessel, Co-Founder and Managing Director, Symphony Capital, LLC
Ruth Levine, PhD, Vice President of Programs and Operations, Center for Global Development
Margaret G. McGlynn, President, Merck Vaccines
Ting Pau Oei, Partner, L Capital Management, LLC
Arthur M. Pappas, Managing Partner, Pappas Ventures
Dennis J. Purcell, Senior Managing Director, Aisling Capital, LLC
Steven G. Reed, PhD, Founder, Director, Head of Research and Development Infectious Disease Research Institute
Una S. Ryan, PhD, OBE, CEO, AVANT Immunotherapeutics
Ken Stuart, PhD, Co-founder, President and Director, Seattle Biomedical Research Institute
Henri A. Termeer, Chairman, President and CEO, Genzyme Corporation